BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24058388)

  • 1. Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysis.
    VanderWalde NA; Meyer AM; Liu H; Tyree SD; Zullig LL; Carpenter WR; Shores CD; Weissler MC; Hayes DN; Fleming M; Chera BS
    J Geriatr Oncol; 2013 Jul; 4(3):262-70. PubMed ID: 24058388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
    Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
    Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.
    Baxi SS; O'Neill C; Sherman EJ; Atoria CL; Lee NY; Pfister DG; Elkin EB
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E165-71. PubMed ID: 25535104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
    Sher DJ; Neville BA; Chen AB; Schrag D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of chemoradiation for head and neck cancer in an older patient population.
    VanderWalde NA; Meyer AM; Deal AM; Layton JB; Liu H; Carpenter WR; Weissler MC; Hayes DN; Fleming ME; Chera BS
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):30-7. PubMed ID: 24725687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    Rettig EM; D'Souza G; Thompson CB; Koch WM; Eisele DW; Fakhry C
    Cancer; 2016 Jun; 122(12):1861-70. PubMed ID: 27182694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
    Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
    Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer.
    Sharma A; Schwartz SM; Méndez E
    Cancer; 2013 May; 119(10):1845-52. PubMed ID: 23456789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery?
    Wan XC; Egloff AM; Johnson J
    Laryngoscope; 2012 Dec; 122(12):2712-22. PubMed ID: 23060119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
    Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
    Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: a SEER-Medicare database study.
    Stott-Miller M; Chen C; Schwartz SM
    Cancer Epidemiol; 2013 Aug; 37(4):428-33. PubMed ID: 23562170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
    Chang CL; Yuan KS; Wu SY
    Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients.
    Hansen CC; Egleston B; Leachman BK; Churilla TM; DeMora L; Ebersole B; Bauman JR; Liu JC; Ridge JA; Galloway TJ
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1136-1146. PubMed ID: 33090191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Medicare effect" on head and neck cancer diagnosis and survival.
    Smith JB; Jayanth P; Hong SA; Simpson MC; Massa ST
    Head Neck; 2023 Jul; 45(7):1663-1675. PubMed ID: 37096786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.
    Smith GL; Smith BD; Buchholz TA; Liao Z; Jeter M; Swisher SG; Hofstetter WL; Ajani JA; McAleer MF; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):482-9. PubMed ID: 19289262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study.
    Kim R; Ock CY; Keam B; Kim TM; Kim JH; Paeng JC; Kwon SK; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
    BMC Cancer; 2016 Feb; 16():116. PubMed ID: 26884055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
    Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.